Intravascular imaging guided versus coronary angiography guided percutaneous coronary intervention: systematic review

Safi U Khan1, Siddharth Agarwal2, Hassaan B Arshad1

  • 1Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston, TX, USA.

BMJ (Clinical Research Ed.)
|November 16, 2023
PubMed

Insights

Intravascular imaging guidance for percutaneous coronary intervention significantly reduces cardiac death and adverse cardiovascular events in patients with coronary artery disease. These benefits increase with higher patient baseline risk, showing substantial absolute risk reductions.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology

Background:

  • Percutaneous coronary intervention (PCI) is a cornerstone in managing coronary artery disease (CAD).
  • Optimal PCI guidance remains crucial for improving patient outcomes.
  • Intravascular imaging (IVI) offers detailed vessel visualization beyond standard angiography.

Approach:

  • Systematic review and meta-analysis of 20 randomized controlled trials (RCTs) involving 11,698 patients.
  • Compared IVI-guided PCI (using intravascular ultrasonography or optical coherence tomography) with angiography-guided PCI.
  • Utilized random-effects meta-analysis and GRADE methodology to assess evidence certainty and absolute risk differences based on SYNTAX risk categories.

Key Points:

  • IVI-guided PCI significantly reduced risks of cardiac death (RR 0.53), myocardial infarction (RR 0.81), stent thrombosis (RR 0.44), and revascularization events.
  • High certainty evidence demonstrated absolute risk reductions per 1000 people: 23-64 fewer cardiac deaths, 15-19 fewer MIs, 9-13 fewer stent thromboses, 28-38 fewer TVRs, and 35-48 fewer TLRs.
  • Absolute benefits were proportional to baseline cardiovascular risk, highlighting the importance of IVI in higher-risk patients.

Conclusions:

  • IVI-guided PCI is superior to angiography-guided PCI for improving cardiovascular outcomes in CAD patients.
  • The absolute treatment effect of IVI-guided PCI is significantly influenced by patient baseline risk, particularly in those with complex coronary artery disease.
  • These findings support the routine use of intravascular imaging to optimize PCI strategy and reduce adverse events.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
20
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
25
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
9
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
11
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
9